Literature DB >> 15478123

Amyloid myopathy: characteristic features of a still underdiagnosed disease.

John E Chapin1, Mario Kornfeld, Alexis Harris.   

Abstract

A 62-year-old man with progressive proximal weakness underwent extensive evaluation including muscle biopsy without a clear diagnosis being established. A repeat muscle biopsy including Congo red-stained sections revealed infiltration of blood-vessel walls and endomysium with amyloid protein, as well as an unusual pattern of pathologic changes to muscle fibers. From a review of 79 cases of amyloid myopathy reported in the English-language literature, the characteristic features of this disorder are described. Congo red-stained sections of muscle biopsy viewed under fluorescent or polarized optics, and serum or urine protein immunoelectrophoresis, play an important role in the evaluation of myopathy. Amyloid myopathy should be a consideration in adults with progressive neuromuscular weakness of uncertain cause.

Entities:  

Mesh:

Year:  2005        PMID: 15478123     DOI: 10.1002/mus.20169

Source DB:  PubMed          Journal:  Muscle Nerve        ISSN: 0148-639X            Impact factor:   3.217


  13 in total

Review 1.  Systemic amyloidosis: a challenge for the rheumatologist.

Authors:  Federico Perfetto; Alberto Moggi-Pignone; Riccardo Livi; Alessio Tempestini; Franco Bergesio; Marco Matucci-Cerinic
Journal:  Nat Rev Rheumatol       Date:  2010-06-08       Impact factor: 20.543

2.  Muscle Hypertrophy in a Patient with Immunoglobulin D Multiple Myeloma.

Authors:  Shingo Suzuki; Yoshiyuki Ohira; Masatomi Ikusaka
Journal:  J Gen Intern Med       Date:  2016-05       Impact factor: 5.128

3.  Amyloid myopathy with external ophthalmoparesis.

Authors:  Akihiko Hoshi; Masahiro Ebitani; Gaku Tanaka; Kouichirou Nakamura; Ken Shibano; Nozomu Matsuda; Masafumi Abe; Yoshikazu Ugawa
Journal:  J Neurol       Date:  2009-04-27       Impact factor: 4.849

4.  Amyloid myopathy as the presenting feature of lymphoplasmacytic lymphoma.

Authors:  Zain Guduru; Abhishek Purohit; Cunfeng Pu; Sandeep Rana
Journal:  Ann Indian Acad Neurol       Date:  2017 Jan-Mar       Impact factor: 1.383

5.  Amyloid myopathy: a therapeutic trial for the rare and underdiagnosed myopathy with bortezomib.

Authors:  Kensuke Shiga; Reiko Mizutani; Reina Isayama; Chihiro Shimazaki; Takahiko Tokuda; Masanori Nakagawa
Journal:  J Neurol       Date:  2010-07-08       Impact factor: 4.849

6.  Polymyositis, a very uncommon isolated disease: clinical and histological re-evaluation after long-term follow-up.

Authors:  Veronica Silva Vilela; Sergio Prieto-González; José C Milisenda; Albert Selva-O Callaghan; Josep M Grau
Journal:  Rheumatol Int       Date:  2014-12-30       Impact factor: 2.631

7.  Expanding the spectrum of monoclonal light chain deposition disease in muscle.

Authors:  Lyle W Ostrow; Andrea M Corse; Brett M Morrison; Carol A Huff; John A Carrino; Ahmet Hoke; Andrew L Mammen
Journal:  Muscle Nerve       Date:  2012-05       Impact factor: 3.217

8.  Familial amyloidotic polyneuropathy with muscle, vitreous, leptomeningeal, and cardiac involvement: phenotypic, pathological, and MRI description.

Authors:  D K Prashantha; Arun B Taly; Sanjib Sinha; T Chikkabasavaiah Yasha; Narayanappa Gayathri; J M E Kovur; Joy Vijayan
Journal:  Ann Indian Acad Neurol       Date:  2010-04       Impact factor: 1.383

9.  Chronic myopathy due to immunoglobulin light chain amyloidosis.

Authors:  Irini Manoli; Justin Y Kwan; Qian Wang; Elisabeth J Rushing; Maria Tsokos; Andrew E Arai; Warner M Burch; Angela Dispenzieri; Alexandra C McPherron; William A Gahl
Journal:  Mol Genet Metab       Date:  2013-02-04       Impact factor: 4.797

10.  Amyloid myopathy: a diagnostic challenge.

Authors:  Heli Tuomaala; Mikko Kärppä; Hannu Tuominen; Anne M Remes
Journal:  Neurol Int       Date:  2009-11-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.